Phase I study to evaluate safety and immunogenicity of V-212 in healthy adult volunteers.
This early-stage clinical trial is studying a new experimental vaccine known as V-212. The study is aimed at healthy adult volunteers aged 18 and over. Because this is a Phase 1 trial, its main purpose is safety. The research team wants to check how the human body handles V-212 and watch closely for any unwanted side effects. Researchers will also look at the vaccine's 'immunogenicity', which means checking whether it encourages the immune system to produce protective antibodies. Taking part involves health checks, receiving the vaccine, and attending clinic visits so doctors can monitor your wellbeing and collect blood samples. Early trials like this are essential to learn if a new vaccine is safe enough to be tested in larger groups of people in the future. Joining is entirely voluntary, and you may leave the study at any time.
At a glance
What is this study about?
Before any new vaccine can be offered to the public, it must go through careful scientific testing. This study is an early-stage clinical trial, often called Phase 1. It is designed to test an experimental vaccine named V-212 in humans to find out how safe it is and how the body responds to it.
Along with safety, the trial looks at the immune response. Researchers want to see if V-212 triggers the body to build defences, such as antibodies, that could help fight off illness. By studying healthy volunteers first, doctors can get a clear picture of how the vaccine works without other health conditions confusing the results.
Trials of this kind are a vital starting point in medical research. The findings help scientists decide whether V-212 works well enough and is gentle enough on the body to move on to larger studies involving more people.
Key takeaways
- Tests an experimental vaccine called V-212 in healthy adults aged 18 and older.
- Mainly designed to check safety, side effects, and the body's immune response.
- First-stage (Phase 1) study with regular health checks and close medical supervision.
- Involves clinic visits for health assessments, the injection, and follow-up blood tests.
- Participation is entirely voluntary, and you are free to leave at any time.
Who may be eligible?
This trial is open to healthy adults who are 18 years of age or older. Both men and women are welcome to take part.
Because this is an early safety study, volunteers generally need to be in good overall health. People with serious long-term illnesses, active infections, or immune system disorders are usually unable to join, as these conditions could make taking part unsafe or alter the results.
The study team will review your full medical history and perform standard health checks to confirm whether it is safe and suitable for you to join.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I am at least 18 years old.
- I consider myself to be in good general health.
- I do not have a serious long-term medical condition.
- I am able to travel to the clinic for scheduled appointments.
- I am willing to receive an experimental vaccine and have routine blood tests.
What does participation involve?
If you choose to take part, you will first visit the clinic for a screening appointment. The medical team will check your overall health using routine checks, such as measuring your blood pressure and taking blood samples. If you are eligible and agree to take part, you will receive the V-212 vaccine.
After vaccination, you will need to attend several follow-up appointments over a set period. During these visits, doctors will check how you are feeling, check for any side effects, and take further blood samples to see how your immune system is responding. The study doctors will give you a clear schedule of visits and explain the total length of the study before you decide to join.
Potential risks and benefits
Locations (1)
- —UnverifiedBelgium
Common questions
What is a Phase 1 clinical trial?
A Phase 1 trial is the earliest stage of testing in humans. It focuses mainly on finding out if a new treatment is safe and what side effects it might cause.
Will I be paid for taking part?
Phase 1 trials involving healthy volunteers often offer payment or cover travel expenses to compensate you for your time and effort. The trial team will give you specific details about this.
Can I carry on seeing my own GP?
Yes. Taking part in a trial does not replace your usual NHS care. With your agreement, the research team will let your GP know that you are taking part.
What happens if I feel unwell during the trial?
The research team will give you emergency contact details available 24 hours a day. Medical professionals will be on hand to check your symptoms and provide care if needed.
Can I leave the study if I change my mind?
Yes, taking part is completely voluntary. You can stop participating at any time, and you do not have to provide a reason.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.